<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
	<title>nyheter om biotech och life science</title>
	<link>http://lifescience.idg.se</link>
	<description>Nyheter Life Science Sweden</description>

	<language>sv</language>
	<lastBuildDate>Fri, 24 May 2013 01:03:22 +0200</lastBuildDate>
	<copyright>Copyright 1998-2010 INTERNATIONAL DATA GROUP. All Rights Reserved.</copyright>
	<webMaster>webmaster@idg.se (IDG Webmaster)</webMaster>
    <item>
	<guid>http://lifescience.idg.se/2.1763/1.508985/ny-pms-behandling-testas-pa-patienter</guid><title>Testar PMS-kur p&#229; patienter </title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508985.1369321142!teaserImage/imageTypeSelector/localImage/2578764206.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Ume&#229;bolaget Umecrine Mood doserar f&#246;rsta patienten i en fas I/II-studie med bolagets preparat mot premenstruella besv&#228;r. </description>
		<link>http://lifescience.idg.se/2.1763/1.508985/ny-pms-behandling-testas-pa-patienter</link>
		<pubDate>Thu, 23 May 2013 16:58:32 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Kliniska studier</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>umecrine mood</category>
		<category>karolinska development</category>
		<category>karin ekberg</category>
		<category>marie bixo</category>
		<category>torbj&#246;rn bjerke</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508938/sa-maste-foretagen-anpassa-sig-till-marknaden</guid><title>S&#229; m&#229;ste f&#246;retagen anpassa sig till marknaden</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508938.1369318325!teaserImage/imageTypeSelector/localImage/2213156058.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Life science-f&#246;retag m&#229;ste &#228;ndra sina strategier om de ska &#246;verleva n&#228;r sjukv&#229;rden v&#228;rlden &#246;ver stramar &#229;t sina budgetar. Hur det ska g&#229; till diskuterades p&#229; Bioequity.</description>
		<link>http://lifescience.idg.se/2.1763/1.508938/sa-maste-foretagen-anpassa-sig-till-marknaden</link>
		<pubDate>Thu, 23 May 2013 14:52:26 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Bransch</category>
		<category>Finansiering eller st&#246;d</category>
		<category>Regulatory (myndighetsans&#246;kan, godk&#228;nnande)</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>thomas l&#246;nngren</category>
		<category>bioequity europe</category>
		<category>geoffrey mcdonough</category>
		<category>sobi</category>
		<category>ema</category>
		<category>stefan larsson</category>
		<category>boston consulting group</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508738/fokus-pa-finansiering-och-imi-20</guid><title>Fokus p&#229; medel och IMI 2.0</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508738.1369318324!teaserImage/imageTypeSelector/localImage/928590346.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Med IMI 2.0 i ant&#229;gande diskuterade en internationell panel p&#229; investerarm&#228;ssan Bioequity fr&#229;gan om hur EU-finansiering och riskkapital kan g&#246;ra Europa konkurrenskraftigt f&#246;r innovationer i tidig utvecklingsfas. </description>
		<link>http://lifescience.idg.se/2.1763/1.508738/fokus-pa-finansiering-och-imi-20</link>
		<pubDate>Wed, 22 May 2013 17:42:47 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>imi</category>
		<category>eu</category>
		<category>werner lanthaler</category>
		<category>bioequity</category>
		<category>astrazenecas sverigevd anders ekblom</category>
		<category>europe</category>
		<category>fp7</category>
		<category>promethera biosciences</category>
		<category>innovative medicines initiative</category>
		<category>efpias</category>
		<category>torbj&#246;rn bjerke</category>
		<category>karolinska development</category>
		<category>evotec</category>
		<category>rafačle tordjman</category>
		<category>sofinnova</category>
		<category>eric halioua</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508797/johan-jarte-kliver-pa-styrelsen-i-ict</guid><title>Johan J&#228;rte kliver p&#229; styrelsen i ICT</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508797.1369294560!teaserImage/imageTypeSelector/localImage/2149130985.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Blir ledamot och medicinsk r&#229;dgivare i v&#229;rdbolag.</description>
		<link>http://lifescience.idg.se/2.1763/1.508797/johan-jarte-kliver-pa-styrelsen-i-ict</link>
		<pubDate>Thu, 23 May 2013 09:40:08 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>ict</category>
		<category>johan j&#228;rte</category>
		<category>patrik &#229;vestrand</category>
		<category>janssen-cilag</category>
		<category>serorno</category>
		<category>sentoclone</category>
		<category>cathprint</category>
		<category>international clinical testing</category>
		<category>pharmacia</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508699/affibody-i-licensavtal-med-daewoong</guid><title>Affibody i avtal med Daewoong </title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508699.1369290542!teaserImage/imageTypeSelector/localImage/4188828611.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Tecknar avtal om Albumod-plattformen.</description>
		<link>http://lifescience.idg.se/2.1763/1.508699/affibody-i-licensavtal-med-daewoong</link>
		<pubDate>Wed, 22 May 2013 16:50:33 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Biotech</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>daewoong pharmaceutical</category>
		<category>affibody</category>
		<category>albumod</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508478/unik-genussajt-ska-hjalpa-forskrivare</guid><title>Biverkningar under lupp</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508478.1369231798!imageUploader/2087498637.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Kvinnor och m&#228;n reagerar olika p&#229; l&#228;kemedel. Men hur? Det ska l&#228;kare snabbt f&#229; koll p&#229; genom beslutsst&#246;det Genus p&#229; Janus.</description>
		<link>http://lifescience.idg.se/2.1763/1.508478/unik-genussajt-ska-hjalpa-forskrivare</link>
		<pubDate>Wed, 22 May 2013 11:49:50 +0200</pubDate>
		<category>It i v&#229;rden</category>
		<category>Forskning</category>
		<category>Teknik</category>
		<category>janus</category>
		<category>karin schenck-gustafsson</category>
		<category>l&#228;kemedelsverket</category>
		<category>fda</category>
		<category>ace</category>
		<category>karolinska</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508534/klinisk-forskning---ett-nodvandigt-ont</guid><title>Klinisk forskning - ett n&#246;dv&#228;ndigt ont</title>
		<description>Under en paneldebatt diskuterades hur v&#229;rden ska g&#246;ra plats f&#246;r kliniska pr&#246;vningar och varf&#246;r den kliniska forskningen m&#229;ste ta plats just i Sverige. </description>
		<link>http://lifescience.idg.se/2.1763/1.508534/klinisk-forskning---ett-nodvandigt-ont</link>
		<pubDate>Wed, 22 May 2013 12:33:36 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>johan brun</category>
		<category>pfizer</category>
		<category>kancera</category>
		<category>sweden bios</category>
		<category>tomas olin</category>
		<category>erik weiman</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508392/sweden-bio-rekryterar-nytt-till-styrelsen</guid><title>Sweden Bio rekryterar nytt</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508392.1369293054!teaserImage/imageTypeSelector/localImage/2742431381.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Fyra nya ledam&#246;ter klubbades igenom vid &#229;rsst&#228;mman p&#229; tisdagsf&#246;rmiddagen.</description>
		<link>http://lifescience.idg.se/2.1763/1.508392/sweden-bio-rekryterar-nytt-till-styrelsen</link>
		<pubDate>Tue, 21 May 2013 22:23:10 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>sweden bios</category>
		<category>anders ekblom</category>
		<category>astrazeneca</category>
		<category>jan erneberg</category>
		<category>healthcare</category>
		<category>yvonne m&#229;rtensson</category>
		<category>cellavision</category>
		<category>ap</category>
		<category>elekta</category>
		<category>ortivus</category>
		<category>ulrika sl&#229;ne</category>
		<category>akbar seddigh</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508440/affibody-far-branschpris</guid><title>Affibody f&#229;r branschpris</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508440.1369293055!teaserImage/imageTypeSelector/localImage/583984158.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Sweden Bio Award delades ut till forskningsf&#246;retaget.</description>
		<link>http://lifescience.idg.se/2.1763/1.508440/affibody-far-branschpris</link>
		<pubDate>Tue, 21 May 2013 22:37:04 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Priser, stipendier och utm&#228;rkelser</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>affibody</category>
		<category>sweden bio award</category>
		<category>sweden bios</category>
		<category>per lagerkvist</category>
		<category>delphi</category>
		<category>david bejker</category>
		<category>kth</category>
		<category>karolinska</category>
		<category>aby</category>
		<category>her2</category>
		<category>pet</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508388/nya-eu-regler-paverkar-life-science-branschen</guid><title>Nya EU-regler p&#229;verkar life science-branschen</title>
		<description>Stora regulatoriska f&#246;r&#228;ndringar p&#229; g&#229;ng i EU.</description>
		<link>http://lifescience.idg.se/2.1763/1.508388/nya-eu-regler-paverkar-life-science-branschen</link>
		<pubDate>Wed, 22 May 2013 12:33:42 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>eu</category>
		<category>sweden bios</category>
		<category>alexander natz</category>
		<category>eucope</category>
		<category>l&#228;kemedelsindustrif&#246;reningen</category>
		<category>lif</category>
		<category>tyskland</category>
		<category>transperency</category>
		<category>abbvie</category>
		<category>humira</category>
		<category>gdp</category>
		<category>ema</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508534/klinisk-forskning---ett-nodvandigt-ont</guid><title>Klinisk forskning - ett n&#246;dv&#228;ndigt ont</title>
		<description>Under en paneldebatt diskuterades hur v&#229;rden ska g&#246;ra plats f&#246;r kliniska pr&#246;vningar och varf&#246;r den kliniska forskningen m&#229;ste ta plats just i Sverige. </description>
		<link>http://lifescience.idg.se/2.1763/1.508534/klinisk-forskning---ett-nodvandigt-ont</link>
		<pubDate>Wed, 22 May 2013 12:33:36 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>johan brun</category>
		<category>pfizer</category>
		<category>kancera</category>
		<category>sweden bios</category>
		<category>tomas olin</category>
		<category>erik weiman</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508441/scilifelab-far-ny-organisation</guid><title>Scilifelabs nya ledning</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508441.1369214204!teaserImage/imageTypeSelector/localImage/338802513.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Nio styrelseledam&#246;ter &#228;r p&#229; plats och tv&#229; ledningspositioner &#228;r fyllda. Men &#228;n &#228;r inte all rekrytering klar. </description>
		<link>http://lifescience.idg.se/2.1763/1.508441/scilifelab-far-ny-organisation</link>
		<pubDate>Wed, 22 May 2013 06:54:00 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>scilifelab</category>
		<category>mathias uhl&#233;n</category>
		<category>kerstin lindblad-toh</category>
		<category>g&#246;ran sandberg</category>
		<category>knut</category>
		<category>margareta olsson birgersson</category>
		<category>roche sweden</category>
		<category>mikaela friedman</category>
		<category>hans adolfsson</category>
		<category>stockholmsnoden</category>
		<category>uppsalanoden</category>
		<category>sophia hober</category>
		<category>fakultets dekanus</category>
		<category>britt skogseid</category>
		<category>gustaf ljunggren</category>
		<category>karolinska institutet</category>
		<category>maria anvret</category>
		<category>gunilla westergren-thorsson</category>
		<category>karl-eric magnusson</category>
		<category>alice wallenberg</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508437/sanofi-pasteur-msd-far-ny-nordenchef</guid><title>Sanofi Pasteur MSD  f&#229;r ny Nordenchef </title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508437.1369234256!teaserImage/imageTypeSelector/localImage/4113802067.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Rolf Carlsson axlar rollen och tar plats vid bolagets nordiska huvudkontor i Solna.&#160;</description>
		<link>http://lifescience.idg.se/2.1763/1.508437/sanofi-pasteur-msd-far-ny-nordenchef</link>
		<pubDate>Wed, 22 May 2013 06:08:00 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Vd-kollen</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>sanofi pasteur msd</category>
		<category>rolf carlsson</category>
		<category>einar vollan</category>
		<category>zostavax</category>
		<category>gilead science</category>
		<category>hexyon</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.503564/biotech-tar-revansch</guid><title>Biotech p&#229; rekordniv&#229;er</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.503564.1369062011!teaserImage/imageTypeSelector/localImage/3673094959.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;F&#246;r f&#246;rsta g&#229;ngen sedan biotech-bubblan sprack &#229;r 2000 har biotech-bolagen h&#228;mtat sig. Men den h&#228;r g&#229;ngen v&#228;rderas sektorn p&#229; b&#228;ttre grunder, enligt Redeyes analytiker.</description>
		<link>http://lifescience.idg.se/2.1763/1.503564/biotech-tar-revansch</link>
		<pubDate>Tue, 21 May 2013 07:36:00 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>biotech</category>
		<category>pa redeye</category>
		<category>peter ostling</category>
		<category>bill clinton</category>
		<category>tony blair</category>
		<category>nasdaq omx stockholm</category>
		<category>meda</category>
		<category>getinge</category>
		<category>astra zeneca</category>
		<category>joakim von anka</category>
		<category>hugo</category>
		<category>elekta</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508348/halla-dar-christian-schneider-</guid><title>Hall&#229; d&#228;r Christian Schneider ...</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508348.1369168012!teaserImage/imageTypeSelector/localImage/4135160499.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;...ordf&#246;rande f&#246;r kommitt&#233;n f&#246;r avancerade terapier, CAT, inom EMA. Vilka &#228;r era utmaningar?</description>
		<link>http://lifescience.idg.se/2.1763/1.508348/halla-dar-christian-schneider-</link>
		<pubDate>Tue, 21 May 2013 13:32:47 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Hall&#229; d&#228;r</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>christian schneider</category>
		<category>cat</category>
		<category>chmp</category>
		<category>ema</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508199/actavis-koper-rival</guid><title>Actavis k&#246;per upp rival</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508199.1369120034!teaserImage/imageTypeSelector/localImage/630245808.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;F&#246;rv&#228;rvar l&#228;kemedelsbolag f&#246;r fem miljarder dollar. </description>
		<link>http://lifescience.idg.se/2.1763/1.508199/actavis-koper-rival</link>
		<pubDate>Mon, 20 May 2013 15:39:46 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Pharma</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>actavis</category>
		<category>warner chilcott</category>
		<category>paul bisaro</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508228/socialt-entreprenorskap--del-av--affarsmodellen</guid><title>Socialt entrepren&#246;rskap - del av aff&#228;rsmodellen</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508228.1369060594!teaserImage/imageTypeSelector/localImage/2926073775.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Nyt&#228;nkande och samverkan kr&#228;vs f&#246;r att m&#246;jligg&#246;ra en ny karri&#228;r flera g&#229;nger under livet, skriver Jenni Nordborg i sin kr&#246;nika. </description>
		<link>http://lifescience.idg.se/2.1763/1.508228/socialt-entreprenorskap--del-av--affarsmodellen</link>
		<pubDate>Mon, 20 May 2013 16:40:31 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Kr&#246;nikor</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>cses</category>
		<category>fredrik reinfeld</category>
		<category>jenni nordborg</category>
		<category>vinnova</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.503575/translationellt-center-efter-sommaren</guid><title>Translationellt efter sommaren</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.503575.1368801232!teaserImage/imageTypeSelector/localImage/2267686131.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;20-30 forskare fr&#229;n Astrazeneca och KI ska driva l&#228;kemedelsj&#228;ttens andra translationella forskningscenter. Men &#228;n &#228;r inga papper undertecknade och detaljerna &#228;r oklara.</description>
		<link>http://lifescience.idg.se/2.1763/1.503575/translationellt-center-efter-sommaren</link>
		<pubDate>Mon, 20 May 2013 06:33:00 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>karolinska</category>
		<category>astra zenecas sodertaljeverksamhet</category>
		<category>astra zeneca translational science center</category>
		<category>jacob lund</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508001/europeiskt-fokus-pa-ibd</guid><title>Europeiskt fokus p&#229; IBD </title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508001.1369036765!teaserImage/imageTypeSelector/localImage/827178298.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;F&#229;r finansiering fr&#229;n EU. Akademi och industri g&#229;r samman f&#246;r att g&#229; till botten med tarmsjukdomen.</description>
		<link>http://lifescience.idg.se/2.1763/1.508001/europeiskt-fokus-pa-ibd</link>
		<pubDate>Mon, 20 May 2013 06:25:00 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Biotech</category>
		<category>Forskning</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>ibs</category>
		<category>eu</category>
		<category>olink bioscience</category>
		<category>mats gullberg</category>
		<category>fp7</category>
		<category>karolinska</category>
		<category>diagenode</category>
		<category>genetic analysis</category>
		</item>
<item>
	<guid>http://lifescience.idg.se/2.1763/1.508192/nanobolag-far-pris</guid><title>Nanobolag  f&#229;r pris</title>
		<description>&#60;img src=&#34;http://lifescience.idg.se/polopoly_fs/1.508192.1369055874!teaserImage/imageTypeSelector/localImage/4038111235.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Nanologica blev &#229;rets nanof&#246;retag.</description>
		<link>http://lifescience.idg.se/2.1763/1.508192/nanobolag-far-pris</link>
		<pubDate>Mon, 20 May 2013 15:04:24 +0200</pubDate>
		<category>Life Science Sweden</category>
		<category>Biotech</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Priser, stipendier och utm&#228;rkelser</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>nanologica</category>
		<category>swednanotech</category>
		<category>nanolek</category>
		<category>vinnova</category>
		</item>
</channel>
</rss>